Tsingke Biotechnology Co.

BiotechnologySeries BBeijing, Chinatsingke.net

Latest round

Series B

Last raised

Dec 2022

Total raised

$88M

Investors

11

About Tsingke Biotechnology Co.

, Ltd. is a biotechnology company that focuses on R&D of synthetic genomics and biosynthetic products. The company has clean production workshops, automated production equipment, and R&D center covering 12,000 square meters. Moreover, it passed the CNAS quality system certification, and national high-tech enterprise certification., Ltd. has 1,700 employees. Besides, the company has 122 patents, including 53 invention patents. Also, the company's businesses covered China, US, and German, and served for 120,000 clients., Ltd. The company's products and services can be divided into three categories, including synthetic genomics products and services, life science R&D equipment and raw materials, and contract development and manufacturing organization (CDMO) and contract research organization (CRO). For synthetic genomics field, the company completed about 200 million base syntheses, and manufactured 200 of nucleic acid raw materials and consumables every year. The company self-developed 768-channel blow-pressure synthetic equipment, and synthetic genomics production line that enables 160kb gene synthesis.

Who invested in Tsingke Biotechnology Co.

11 investors across 3 rounds

See all investors in Tsingke Biotechnology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 5, 2022

    Amount

    $57M

    Investors

    Locked

  2. Series A

    Jan 28, 2022

    Amount

    $31M

    Investors

    Locked

  3. Angel

    May 16, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Tsingke Biotechnology Co.

Who invested in Tsingke Biotechnology Co.?

Tsingke Biotechnology Co. has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Tsingke Biotechnology Co. raised?

Tsingke Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Tsingke Biotechnology Co. last raise money?

Tsingke Biotechnology Co.'s most recent round on record is a Series B, in Dec 2022.

What does Tsingke Biotechnology Co. do?

Tsingke Biotechnology Co. is a biotechnology company.

Where is Tsingke Biotechnology Co. headquartered?

Tsingke Biotechnology Co. is headquartered in Beijing, China.

Which VCs invest in companies like Tsingke Biotechnology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Tsingke Biotechnology Co.'s stage. Their profiles are linked below.

Raising like Tsingke Biotechnology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.